摘要:
The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
摘要:
Compounds of formula (I), methods of making and method of using (including optical compositions and devices) are provided. The compounds are 1 where A1 is selected from O and S; A2 is selected from nullOH, nullSH, and nullOR3; Rf and Rf1 can be the same or different, can be branched or unbranched, can be linked to form cyclic or extended structures, and are selected from halogenated alkyl, halogenated aryl, halogenated cyclic alkyl, halogenated arylalkyl, halogenated alkylaryl, halogenated polyether, halogenated thioether, halogenated ether thioether, halogenated aklyl amino groups, halogenated alkylene, halogenated silylene, halogenated siloxanes, halogenated silazanes, halogenated olefins, perfluorinated C1-20 alkyl, perfuorinated C1-6 alkyl C1-10 alkyl ethers, n-C8F17, n-C6F13, n-C4F9, n-C2F5, (CF3)2CF(CF2)4, n-C10F21, n-C12F25, (CF3)2CF(CF2)6, and (CF3)2CFO(CF2)2; and R3 can be branched or unbranched and is selected from C1-15 alkyl, C3-15 aryl, C4-15 alkylaryl, and C4-15 arylalkyl. Wherein, (i) if Rf and Rf1 are the same and selected from n-C2F5, n-C4F9, n-C6F13, n-C7F15, and n-C8F17, then A1 is not O; (ii) if Rf and Rf1, are the same and selected from n-C2F5, n-C4F9, n-C6F13, n-C7F15, and n-C8F17, then A2 is not nullOH; and (iii) if A1 is O, and if Rf and Rf1 are the same and selected from n-C6F13, n-C7F15 and n-C8F17, then A2 is not nullOCH3.
摘要:
A process is described for the preparation of R or S aminocarnitine, R or S phosphonium aminocarnitine and R and S 3,4 diaminobutanoic acid, and their derivatives with the following formula: 1 where Y is as described in the attached description, starting from aspartic acid with the same configuration as the desired compounds. This process is advantageous from the industrial point of view in terms of the type of reactants used, the reduced volumes of solvents and the possibility of avoiding purification of the intermediate products.
摘要:
The present invention relates to novel complexes of (transition) metals containing ligands having phosphinimine centers bonded to the (transition) metal.
摘要:
Novel reactions used to prepare phosphole and bisphosphole compounds are detailed. Novel phosphole compounds and metal coordination compounds of phosphole and bisphosphole compounds are also provided. These metal coordination compounds are useful as catalysts for the polymerization or olefins with carbon monoxide and for the polymerization of acrylic monomers.
摘要:
A process for preparing polymerizable biaryl derivatives comprises reacting an aromatic comprising a 6-membered ring which bears ester or benzylic OH groups in the 1,4 position with a second aromatic in a palladium-catalyzed cross-coupling reaction to give a biaryl and converting the ester or benzylic OH groups into polymerizable groups in one or more steps. The biaryls obtained are suitable for preparing polymers which are used as electroluminescence materials.
摘要:
This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
摘要:
Compounds of formula (i), wherein m, R, R1, and R3 to R6 are as defined in the specification, m, is 1, 2 or 3 and X is O or a direct bond, and the corresponding unphosporylated compounds have interesting properties, e.g. immunosuppressive properties. 1
摘要:
This invention is directed to an improved process for the preparation of N-(phosphonomethyl)glycine (i.e., nullglyphosatenull), a salt of N-(phosphonomethyl)glycine, or an ester of N-(phosphonomethyl)glycine. The process comprises combining an N-substituted N-(phosphonomethyl)glycine reactant with oxygen in the presence of a noble metal catalyst. The N-substituted N-(phosphonomethyl)glycine reactant has formula (V): 1 wherein R1 and R2 are independently selected from the group consisting of hydrogen, halogen, nullPO3R12R13, nullSO3R14, nullNO2, hydrocarbyl, and substituted hydrocarbyl other than nullCO2R15; and R7, R8, R9, R12, R13, R14 and R15 are independently selected from the group consisting of hydrogen, hydrocarbyl, substituted hydrocarbyl, and an agronomically acceptable cation.
摘要翻译:本发明涉及制备N-(膦酰基甲基)甘氨酸(即“草甘膦”),N-(膦酰基甲基)甘氨酸的盐或N-(膦酰基甲基)甘氨酸的酯的改进方法。 该方法包括在贵金属催化剂存在下将N-取代的N-(膦酰基甲基)甘氨酸反应物与氧组合。 N-取代的N-(膦酰基甲基)甘氨酸反应物具有式(V):其中R 1和R 2独立地选自氢,卤素,-PO 3 R 12,R 13, SO 3 R 14,-NO 2,烃基和除-CO 2 R 15以外的取代的烃基; 并且R 7,R 8,R 9,R 12,R 13,R 14和R 15独立地选自氢,烃基,取代的烃基, 和农艺学上可接受的阳离子。
摘要:
Aminophosphinic acid derivatives were synthesized as potential inhibitors of renal dipeptidase, an enzyme overexpressed in benign and malignant colon tumors. Several compounds showed potent enzyme-inhibitory activity. These compounds can be used therapeutically and diagnostically for treatment and detection of tumors.